Delivery Order SPE2DB20D3303-SPE2DB25FA1PM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $19,526.18 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL syringes, with an ultimate completion date of July 25, 2025. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement. The award represents a firm fixed-price delivery order, consistent with the company's established pattern of fulfilling pharmaceutical supply...
- The Defense Logistics Agency awarded a $9,158.68 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Enbrel 50 mg/ml syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a near-term pharmaceutical supply requirement within the military healthcare supply chain. This award is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,486 delivery order on July 24, 2025, for Enbrel 25 mg/0.5 mL syringes under a firm fixed price contract type with no set-aside designation. The order, designated as a child contract action, is set for completion by July 25, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $13,844.92 delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's established role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order valued at $23,640.57 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick prefilled syringes on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete for...
- The Defense Logistics Agency awarded a delivery order valued at $9,253.56 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,738.89 to AmerisourceBergen Drug Corp for the supply of ENBREL 50 mg/mL syringes. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among eligible vendors. This...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $8,149.88 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENBREL 25 MG/0.5 ML SYRINGE 0.5ML, a specialty medication, with a completion date of September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML syringes. The award, valued at $8,591.28, is a firm-fixed-price contract with a completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,631.90 firm fixed-price delivery order is for the supply of ENBREL 50 MG/ML syringes. The contract has an ultimate completion date of February 21, 2025 and was awarded on February 20, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1PMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml syringes valued at $9,949.47 on July 21, 2025, with completion anticipated by July 22, 2025. This competitive, non-set-aside award utilizes firm fixed pricing under a delivery order contract type and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to the federal healthcare system. This delivery order is issued against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support military healthcare programs worldwide. The contract supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through flexible procurement arrangements aligned with DLA's pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 7/21/25 |